Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis

Published:2019-03-28 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Schultz Andre,Marsh Julie A.,Saville Benjamin R.,Norman Richard,Middleton Peter G.,Greville Hugh W.,Bellgard Matthew I.,Berry Scott M.,Snelling Tom

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Prognostication and risk factors for cystic fibrosis via automated machine learning.;Alaa;Sci. Rep.,2018

2. Adaptive global innovative learning environment for glioblastoma: GBM AGILE.;Alexander;Clin. Cancer Res.,2018

3. Fusing randomized trials with big data: the key to self-learning health care systems?;Angus;JAMA,2015

4. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.;Bakker;Pediatr. Pulmonol.,2014

5. Dispelling myths about rare disease registry system development.;Bellgard;Source Code Biol. Med.,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. REMAP Periop: a randomised, embedded, multifactorial adaptive platform trial protocol for perioperative medicine to determine the optimal enhanced recovery pathway components in complex abdominal surgery patients within a US healthcare system;BMJ Open;2023-12

2. Does the registry speak your language? A case study of the Global Angelman Syndrome Registry;Orphanet Journal of Rare Diseases;2023-10-19

3. The relationship between pragmatism, timing, and study size on impact of randomized trials: a qualitative, hypothesis generating study of trials of systemic corticosteroids for COVID-19;Journal of Clinical Epidemiology;2022-12

4. Bayesian adaptive clinical trial designs for respiratory medicine;Respirology;2022-08-02

5. Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians;BMJ Open Respiratory Research;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3